(Q40957548)

25 September 2017

Autoantibodies following parvovirus B19 infection (English)

1 reference

25 September 2017

1 reference

Kerr JR

1

1 reference

PubMed ID

8852550

25 September 2017

Boyd N

series ordinal

2

1 reference

25 September 2017

1 January 1996

1 reference

25 September 2017

1 reference

25 September 2017

32

1 reference

25 September 2017

1

1 reference

25 September 2017

41-47

1 reference

Molecular, cellular and clinical aspects of parvovirus B19 infection

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

HUMAN PARVOVIRUS ARTHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Human parvovirus infection in early rheumatoid and inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Persistent parvovirus B19 infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Possible induction of systemic lupus erythematosus by human parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Design and production of a target-specific monoclonal antibody to parvovirus B19 capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

The prevalence of antibody to human parvovirus B19 in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Clinical manifestations of human parvovirus B19 in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

HLA and acute arthritis following human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Human parvovirus B19 infection and juvenile chronic polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Contemporary concepts of autoimmunity and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

Molecular mimicry: a mechanism for autoimmune injury 1

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980008-9

7 January 2021

10.1016/S0163-4453(96)80008-9

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8852550